Effect of Physical-Cognitive Training in Older Adults

Condition(s) studied

Investigational drug(s) / intervention(s)

Physical-Cognitive Training: Participants will receive an 8-week physical-cognitive training program using the Blazepod device, consisting of exercises targeting both balance and cognitive skills. Sessions will be conducted three times per week, each lasting one hour.

Conventional Balance Training: Participants will receive an 8-week conventional balance training program. Sessions will be conducted three times per week, each lasting one hour.

Study summary

The study compares the impact of physical-cognitive exercises using Blazepod device versus conventional balance training on multiple outcomes in older adults aged 70 and above. Participants receive an 8-week intervention, three sessions per week for both groups. Outcome measures include balance assessments, fear of falling scales, activity of daily living performance, sleep quality questionnaires, reaction time tests, and cognitive assessments. The study aims to determine whether physical-cognitive training provides additional benefits compared to conventional balance exercises.

Eligibility

Primary outcome measure(s)

• Standartized Mini Mental Test — From enrollment to the end of treatment at 8 weeks
  It is a test used to assess cognitive impairment and changes, scored out of 30 points, with scores below 24 indicating potential dementia.
• Montreal Cognitive Assessment — From enrollment to the end of treatment at 8 weeks
  A brief cognitive screening tool evaluating memory, attention, language, visuospatial skills, and executive function. Scores below 26 suggest possible cognitive impairment.
• Fullerton Advanced Balance Scale — From enrollment to the end of treatment at 8 weeks
  A clinical balance assessment consisting of 10 tasks that test static and dynamic balance, anticipatory postural adjustments, and sensory integration. Total score is changed 0-40 and higher scores indicated better balance.
• Functional Reach Test — From enrollment to the end of treatment at 8 weeks
  Assesses the maximal distance a person can reach forward beyond arm's length while maintaining a fixed base of support. Measures dynamic balance and risk of falling.
• Timed Up and Go Test — From enrollment to the end of treatment at 8 weeks
  Measures the time taken to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. Evaluates mobility, balance and fall risk.
• Modified Falls Efficacy Scale — From enrollment to the end of treatment at 8 weeks
  Assesses fear of falling and confidence in performing daily activities. A self-reported questionnaire measuring perceived confidence in avoiding falls during various daily activities.
• Deary-Liewald Reaction Time Task — From enrollment to the end of treatment at 8 weeks
  Evaluates simple and choice reaction time. A computerized test measuring the speed of cognitive-motor responses to visual stimuli.

Trial sites (1)

More Medipol University trials in Turkey